Compare stocks

Xlife Sciences AG is a Swiss-based company focused on developing and advancing healthcare and life sciences technologies. It operates primarily in the biotechnology and medical technology sectors, concentrating on early-stage life science projects with significant potential in pharmaceuticals, medical devices, diagnostics, and digital health solutions. The company collaborates with research institutions and industry experts to foster innovation and accelerate the commercialization of health-related technologies. Headquartered in Zurich, Switzerland, Xlife Sciences leverages a strategic geographic location to engage with European research hubs and industry partners. The company's unique approach involves investing in and nurturing a diverse portfolio of projects to diversify risk and maximize value creation.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.